Antonio Julià

26.8k total citations · 1 hit paper
73 papers, 2.1k citations indexed

About

Antonio Julià is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Antonio Julià has authored 73 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 21 papers in Rheumatology and 15 papers in Molecular Biology. Recurrent topics in Antonio Julià's work include Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Antonio Julià is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Antonio Julià collaborates with scholars based in Spain, United States and Palestinian Territory. Antonio Julià's co-authors include Sara Marsal, Arnald Alonso, L. Puig, Alba Erra, Juan D. Cañete, María López‐Lasanta, Chenicheri Balakrishnan, Avron H. Ross, Antonio Fernández‐Nebro and Carlos Palacio and has published in prestigious journals such as Blood, Bioinformatics and PLoS ONE.

In The Last Decade

Antonio Julià

70 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analytical Methods in Untargeted Metabolomics: State of the Art in 2015

2015 479 citations Arnald Alonso, Sara Marsal et al. Frontiers in Bioengineering and Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Julià Spain	25	780	416	394	348	267	73	2.1k
Anjali A. Satoskar United States	33	936 1.2×	319 0.8×	553 1.4×	289 0.8×	148 0.6×	113	3.2k
Sara Marsal Spain	28	1.0k 1.3×	942 2.3×	687 1.7×	352 1.0×	200 0.7×	88	2.8k
Robert F. Ritchie United States	28	540 0.7×	242 0.6×	440 1.1×	441 1.3×	144 0.5×	71	2.6k
Naoto Yamaguchi Japan	31	976 1.3×	149 0.4×	604 1.5×	143 0.4×	106 0.4×	105	2.5k
Gloria Gallo United States	32	1.9k 2.5×	446 1.1×	221 0.6×	184 0.5×	313 1.2×	85	3.6k
Tracy Lightfoot United Kingdom	24	696 0.9×	182 0.4×	178 0.5×	205 0.6×	191 0.7×	44	2.1k
Martijn B. A. van Doorn Netherlands	25	421 0.5×	237 0.6×	687 1.7×	118 0.3×	128 0.5×	100	1.9k
Gabriele Stocco Italy	25	681 0.9×	97 0.2×	241 0.6×	267 0.8×	470 1.8×	130	2.1k
Marie Essig France	31	489 0.6×	98 0.2×	561 1.4×	165 0.5×	131 0.5×	114	2.8k
Peter Reizenstein Sweden	24	494 0.6×	303 0.7×	289 0.7×	682 2.0×	133 0.5×	227	2.3k

Countries citing papers authored by Antonio Julià

Since Specialization

Citations

This map shows the geographic impact of Antonio Julià's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Julià with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Julià more than expected).

Fields of papers citing papers by Antonio Julià

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Julià. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Julià. The network helps show where Antonio Julià may publish in the future.

Co-authorship network of co-authors of Antonio Julià

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Julià. A scholar is included among the top collaborators of Antonio Julià based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Julià. Antonio Julià is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schäfer, Samuel, Oleg Sysoev, Sandra Lilja, et al.. (2024). scDrugPrio: a framework for the analysis of single-cell transcriptomics to address multiple problems in precision medicine in immune-mediated inflammatory diseases. Genome Medicine. 16(1). 42–42. 7 indexed citations

Li, Tie, et al.. (2023). [Artículo traducido] Hacia una medicina de precisión en la dermatitis atópica mediante el uso de enfoques moleculares. Actas Dermo-Sifiliográficas. 115(1). T66–T75. 3 indexed citations

Acosta-Colman, I., et al.. (2022). Association of class II HLA alleles with susceptibility to develop immune‐mediated diseases in Paraguayan patients. International Journal of Immunogenetics. 50(1). 12–18. 1 indexed citations

Julià, Antonio, María López‐Lasanta, Francisco J. Blanco, et al.. (2021). Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC Musculoskeletal Disorders. 22(1). 372–372. 12 indexed citations

Pluma, Andrea, Mihaela Micu, Antonio Julià, et al.. (2020). A questionnaire-based study on contraceptive practice in patients with rheumatic disease found no significant difference in age-matched healthy controls. Rheumatology International. 40(9). 1473–1480.

Julià, Antonio, G. Ávila, Raquel Celis, et al.. (2020). Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 196–196. 10 indexed citations

Michelena, Xabier, Helena Borrell, Mireia López-Corbeto, et al.. (2020). Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Seminars in Arthritis and Rheumatism. 50(4). 564–570. 95 indexed citations

Fernández‐Gutiérrez, Benjamín, Javier P. Gisbert, Eugeni Domènech, et al.. (2017). Cardiovascular disease in immune-mediated inflammatory diseases. Medicine. 96(26). e7308–e7308. 35 indexed citations

Alonso, Arnald, Sara Marsal, & Antonio Julià. (2015). Analytical Methods in Untargeted Metabolomics: State of the Art in 2015. Frontiers in Bioengineering and Biotechnology. 3. 23–23. 479 indexed citations breakdown →

10.

Palacio, Carlos, et al.. (2014). Novel Insights into the Regulatory Architecture of CD4+ T Cells in Rheumatoid Arthritis. PLoS ONE. 9(6). e100690–e100690. 21 indexed citations

11.

Julià, Antonio & Sara Marsal. (2013). The Genetic Architecture of Rheumatoid Arthritis: From Susceptibility to Clinical Subphenotype Associations. Current Topics in Medicinal Chemistry. 13(6). 720–731. 10 indexed citations

12.

Palau, Núria, Antonio Julià, Carlos Montilla, et al.. (2013). Genome-wide transcriptional analysis of T cell activation reveals differential gene expression associated with psoriasis. BMC Genomics. 14(1). 825–825. 25 indexed citations

13.

Julià, Antonio, et al.. (2009). An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis. PLoS ONE. 4(10). e7556–e7556. 74 indexed citations

14.

Julià, Antonio, Jason H. Moore, Laia Miquel‐Serra, et al.. (2007). Identification of a two-loci epistatic interaction associated with susceptibility to rheumatoid arthritis through reverse engineering and multifactor dimensionality reduction. Genomics. 90(1). 6–13. 28 indexed citations

15.

Julià, Antonio & Josep Nomdedéu. (2004). Eosinophilic Gastroenteritis or Eosinophilic Chloroma?. Acta Haematologica. 112(3). 164–166. 3 indexed citations

16.

Küstner, Eduardo Chimenos, et al.. (2003). Protocolo de estudio y tratamiento de la Mucositis bucal en los pacientes con hemopatías malignas. 8(1). 10–18. 4 indexed citations

17.

Giralt, J., et al.. (1999). Splenic irradiation as management of ITP. British Journal of Haematology. 105(3). 843–844. 2 indexed citations

18.

Zuazu, J, Antonio Julià, Jorge Sierra, et al.. (1991). Pregnancy outcome in hematologic malignancies. Cancer. 67(3). 703–709. 54 indexed citations

19.

Julià, Antonio, Javier Bueno, Pedro Doménech, et al.. (1990). Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. British Journal of Haematology. 76(2). 250–255. 41 indexed citations

20.

Julià, Antonio & Sherwood P. Miller. (1976). Idiopathic thrombocytopenic purpura in hodgkin's disease after splenectomy. American Journal of Hematology. 1(1). 115–120. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact